Tung‐Ti Chang

615 total citations
27 papers, 475 citations indexed

About

Tung‐Ti Chang is a scholar working on Physiology, Molecular Biology and Complementary and alternative medicine. According to data from OpenAlex, Tung‐Ti Chang has authored 27 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 5 papers in Molecular Biology and 5 papers in Complementary and alternative medicine. Recurrent topics in Tung‐Ti Chang's work include Asthma and respiratory diseases (4 papers), Allergic Rhinitis and Sensitization (3 papers) and Mycobacterium research and diagnosis (3 papers). Tung‐Ti Chang is often cited by papers focused on Asthma and respiratory diseases (4 papers), Allergic Rhinitis and Sensitization (3 papers) and Mycobacterium research and diagnosis (3 papers). Tung‐Ti Chang collaborates with scholars based in Taiwan, United States and India. Tung‐Ti Chang's co-authors include Hung‐Rong Yen, Mao-Feng Sun, Jen‐Huai Chiang, Chieh‐Chen Huang, Ching‐Hsiang Hsu, Mei‐Yao Wu, Chia-Chou Yeh, Tzu-Ping Huang, Chih‐Hsin Muo and Calvin Yu‐Chian Chen and has published in prestigious journals such as PLoS ONE, Molecules and Journal of Ethnopharmacology.

In The Last Decade

Tung‐Ti Chang

25 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tung‐Ti Chang Taiwan 13 136 130 69 63 60 27 475
Sara Mohamed Naguib Abdel Hafez Egypt 14 141 1.0× 46 0.4× 32 0.5× 33 0.5× 70 1.2× 54 527
Kwan‐Il Kim South Korea 12 147 1.1× 76 0.6× 60 0.9× 49 0.8× 55 0.9× 80 476
Paul A. Robinson United Kingdom 13 276 2.0× 72 0.6× 55 0.8× 69 1.1× 40 0.7× 16 930
Tulake Wuniqiemu China 11 160 1.2× 58 0.4× 109 1.6× 27 0.4× 41 0.7× 16 416
In Sik Shin South Korea 11 86 0.6× 46 0.4× 68 1.0× 52 0.8× 67 1.1× 29 366
Arathi R. Setty United States 8 182 1.3× 125 1.0× 86 1.2× 60 1.0× 64 1.1× 13 1.0k
Fangzhou Teng China 14 215 1.6× 69 0.5× 151 2.2× 35 0.6× 57 0.9× 22 557
Xueyi Zhu China 12 178 1.3× 61 0.5× 122 1.8× 27 0.4× 42 0.7× 20 474
La Yi China 13 201 1.5× 65 0.5× 124 1.8× 29 0.5× 46 0.8× 20 496

Countries citing papers authored by Tung‐Ti Chang

Since Specialization
Citations

This map shows the geographic impact of Tung‐Ti Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tung‐Ti Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tung‐Ti Chang more than expected).

Fields of papers citing papers by Tung‐Ti Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tung‐Ti Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tung‐Ti Chang. The network helps show where Tung‐Ti Chang may publish in the future.

Co-authorship network of co-authors of Tung‐Ti Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Tung‐Ti Chang. A scholar is included among the top collaborators of Tung‐Ti Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tung‐Ti Chang. Tung‐Ti Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Shih‐Han, et al.. (2024). Alternative therapy for lymphoma with febrile neutropenia using traditional Chinese medicine: A case report. EXPLORE. 20(6). 103057–103057. 1 indexed citations
3.
Lin, Pei‐Chun, Cheng‐Chieh Lin, Chia‐Ing Li, et al.. (2023). TCM as adjunctive therapy improves risks of respiratory hospitalizations in persons with type 2 diabetes: A retrospective cohort study. Medicine. 102(12). e33318–e33318.
4.
He, Min, Nan Wang, Yu Yan, et al.. (2023). Quality-grade analysis of velvet antler materials using ultra-weak delayed luminescence combined with chemometrics. Quality Assurance and Safety of Crops & Foods. 15(4). 1–10. 6 indexed citations
6.
Nithiyanantham, Srinivasan, Pei‐Ying Pai, Tung‐Ti Chang, et al.. (2019). Synergistic cardiac pathological hypertrophy induced by high-salt diet in IGF-IIRα cardiac-specific transgenic rats. PLoS ONE. 14(6). e0216285–e0216285. 11 indexed citations
7.
Nithiyanantham, Srinivasan, Wei‐Wen Kuo, Pei‐Ying Pai, et al.. (2018). Overexpression of IGF‐IIRα regulates cardiac remodeling and aggravates high salt induced apoptosis and fibrosis in transgenic rats. Environmental Toxicology. 34(2). 210–218. 14 indexed citations
8.
Chiang, Jen‐Huai, Mei‐Yao Wu, Ching‐Mao Chang, et al.. (2017). Complementary Chinese Herbal Medicine Therapy Improves Survival of Patients With Pancreatic Cancer in Taiwan: A Nationwide Population-Based Cohort Study. Integrative Cancer Therapies. 17(2). 411–422. 51 indexed citations
9.
Yen, Hung‐Rong, Chih‐Hsin Muo, Yu‐Chen Lee, et al.. (2017). Complementary traditional Chinese medicine use in Children with cerebral palsy: a nationwide retrospective cohort study in Taiwan. BMC Complementary and Alternative Medicine. 17(1). 155–155. 17 indexed citations
10.
Lin, Yi‐Chun, et al.. (2017). Characteristics of traditional Chinese medicine usage in children with precocious puberty: A nationwide population-based study. Journal of Ethnopharmacology. 205. 231–239. 11 indexed citations
11.
Chang, Tung‐Ti, et al.. (2016). Integration of Chinese Herbal Medicine Therapy Improves Survival of Patients With Chronic Lymphocytic Leukemia. Medicine. 95(21). e3788–e3788. 17 indexed citations
12.
Chang, Tung‐Ti, et al.. (2016). Post-hematopoietic stem cell transplantation in patients with hematologic disorders: Chinese herbal medicine for an unmet need. Journal of Integrative Medicine. 14(5). 322–335. 10 indexed citations
14.
Chen, Kuen‐Bao, Kuan‐Chung Chen, Ya-Lin Chang, et al.. (2016). In Silico Investigation of Traditional Chinese Medicine for Potential Lead Compounds as SPG7 Inhibitors against Coronary Artery Disease. Molecules. 21(5). 588–588. 7 indexed citations
15.
Yen, Hung‐Rong, et al.. (2015). Characteristics of traditional Chinese medicine use for children with allergic rhinitis: A nationwide population-based study. International Journal of Pediatric Otorhinolaryngology. 79(4). 591–597. 43 indexed citations
16.
Yen, Hung‐Rong, et al.. (2015). Prescription patterns of Chinese herbal products for patients with uterine fibroid in Taiwan: A nationwide population-based study. Journal of Ethnopharmacology. 171. 223–230. 34 indexed citations
17.
Chang, Tung‐Ti, et al.. (2014). In Silico Insight into Potent of Anthocyanin Regulation of FKBP52 to Prevent Alzheimer’s Disease. Evidence-based Complementary and Alternative Medicine. 2014(1). 450592–450592. 9 indexed citations
18.
Chen, Kuan‐Chung, et al.. (2012). Investigation of silent information regulator 1 (Sirt1) agonists from Traditional Chinese Medicine. Journal of Biomolecular Structure and Dynamics. 31(11). 1207–1218. 17 indexed citations
19.
Chang, Tung‐Ti, Chieh‐Chen Huang, & Ching-Hsiang Hsu. (2006). Inhibition of Mite-Induced Immunoglobulin E Synthesis, Airway Inflammation, and Hyperreactivity by Herbal Medicine STA-1. Immunopharmacology and Immunotoxicology. 28(4). 683–695. 8 indexed citations
20.
Chang, Tung‐Ti, Chieh‐Chen Huang, & Ching‐Hsiang Hsu. (2006). Clinical evaluation of the Chinese herbal medicine formula STA‐1 in the treatment of allergic asthma. Phytotherapy Research. 20(5). 342–347. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026